The U.S. Supreme Court has rejected the third and final request for review of a Pennsylvania state court ruling that would allow individuals to sue generics makers for failing to update warnings on drug labels.
Source:: Drug Industry Daily
You are here: Home / Drug Industry News / Supreme Court Denies Last Pending Request for Review in Reglan Preemption Case
Leave a Reply